PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Czasopismo
2011 | 6 | 2 | 220-226
Tytuł artykułu

Dyslipidemia in northeastern China

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Dyslipidemia, is a major risk factor for premature coronary artery disease. Our aim was to estimate the prevalence of dyslipidemia (blood lipid abnormalities) and other risk factors associated with coronary artery diseases among an adult population in northeastern China. Throughout the months of September and October of 2007,a population-based cross-sectional study was conducted and a total of 3,815 individuals were included. Total cholesterol (TC), high-density cholesterol (HDL-C), low-density cholesterol (LDL-C), and triglycerides (TG) were measured. A binary logistic regression analysis was conducted to determine risk factors associated with dyslipidemia. The prevalence of hypercholesterolemia, high LDL-C, low HDL-C, and hypertriglyceridemia were 17.3%, 27.8%, 11.66% and 29.85%, respectively. The prevalence of hypertension, central obesity, alcoholic liver disease (ALD), non-ALD, diabetes and metabolic syndrome was higher in serum lipid abnormality groups than in the non-dyslipidemia group (p < 0.001). In a binary logistic regression, hyperlipidemia was positively correlated with age, male, hypertension, high body mass index, etc. There were negative correlations with being female and the level of education a subject had attained. Dyslipidemia is a major risk factor for premature coronary artery diseases and an important public health issue in the northeastern part of China. Dyslipidemia is more frequent than expected based on previous studies. To control dyslipidemia, routine evaluations in clinics and community centers are needed, as well as effective public health education.
Wydawca

Czasopismo
Rocznik
Tom
6
Numer
2
Strony
220-226
Opis fizyczny
Daty
wydano
2011-04-01
online
2011-02-17
Twórcy
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China
autor
  • School of Public Health, JiLin University, 130021, ChangChun, China
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China, sunjiesusan@126.com
autor
  • Hepatology Department, First Hospital of Jilin University, 130021, Changchun, China, junqiniu@yahoo.cn
Bibliografia
  • [1] Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) 2003,16,230 http://dx.doi.org/10.1080/1357628031000116808
  • [2] He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004,110,405–411 http://dx.doi.org/10.1161/01.CIR.0000136583.52681.0D[Crossref]
  • [3] Khashayar P, Mohagheghi A. The correlation between dyslipidemia and coronary artery disease based on angiographic findings in an Iranian population. Acta Med Indones 2010,42,82–85
  • [4] Lei ZM, Ye MX, Fu WG, Chen Y, Fang C, Li J. Levels of serum leptin, cholecystokinin, plasma lipid and lipoprotein. Hepatobiliary Pancreat Dis Int 2008,7,65–69. PMID, 18234641
  • [5] Wang Y. Surgical treatment of portal hypertension. Hepatobiliary Pancreat Dis Int 2002,1,211–214
  • [6] Nishida C, Uauy R, Kumanyika S, Shetty P. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases, process, product and policy implications. Public Health Nutr 2004,7,245–250 [PubMed]
  • [7] China, long-term issues and options in the health transition. ed. Washington, D.C., World Bank, 1992,1–3
  • [8] Zhang L, Qin LQ, Liu AP, Wang PY. Prevalence of risk factors for cardiovascular disease and their associations with diet and physical activity in suburban Beijing, China. J Epidemiol 2010,20,237–243 http://dx.doi.org/10.2188/jea.JE20090119[Crossref]
  • [9] Obesity: preventing and managing the global epidemic, report of a WHO consultation. ed. Geneva, World Health Organization, 1997, 8–11
  • [10] Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005,366,1059–1062 http://dx.doi.org/10.1016/S0140-6736(05)67402-8[Crossref]
  • [11] Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003,11,71
  • [12] Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi 2003,11,72
  • [13] Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007,35,390–419
  • [14] Fuentes R, Uusitalo T, Puska P, Tuomilehto J, Nissinen A. Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries, a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil 2003,10,411–419 http://dx.doi.org/10.1097/01.hjr.0000085247.65733.4f
  • [15] Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987,257,2176–2180 http://dx.doi.org/10.1001/jama.257.16.2176[Crossref]
  • [16] Tao SC, Li YH, Xiao ZK, Cen RC, Zhang HY, Zhuo YL, et al. Serum lipids and their correlates in Chinese urban and rural populations of Beijing and Guangzhou. Int J Epidemiol 1992,21,893–903 http://dx.doi.org/10.1093/ije/21.5.893[Crossref]
  • [17] Li Z, Yang R, Xu G, Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin Chem 2005,51,144–150 http://dx.doi.org/10.1373/clinchem.2004.038646[Crossref]
  • [18] Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998,19Suppl A,A2–11
  • [19] Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs, evidence from a national cross sectional survey. BMJ 2000,321,1322–1325 http://dx.doi.org/10.1136/bmj.321.7272.1322[Crossref]
  • [20] Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993,269,3002–3008 http://dx.doi.org/10.1001/jama.269.23.3002[Crossref]
  • [21] Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al. Prevalence of coronary heart disease and risk factors in an urban Indian population, Jaipur Heart Watch-2. Indian Heart J 2002,54,59–66
  • [22] Chang HY, Yeh WT, Chang YH, Tsai KS, Pan WH. Prevalence of dyslipidemia and mean blood lipid values in Taiwan, results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993–1996). Chin J Physiol 2002,45,187–197
  • [23] Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998,81,7B–12B http://dx.doi.org/10.1016/S0002-9149(98)00031-9[Crossref]
  • [24] Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, et al. Serum lipid levels in an Iranian adults population, Tehran Lipid and Glucose Study. Eur J Epidemiol 2003,18,311–319. PMID, 12803371 http://dx.doi.org/10.1023/A:1023606524944
  • [25] Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000,8,605–619 http://dx.doi.org/10.1038/oby.2000.79[Crossref]
  • [26] Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998,280,2001–2007 http://dx.doi.org/10.1001/jama.280.23.2001[Crossref]
  • [27] Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease, predicting risks by levels and ratios. Ann Intern Med 1994,121,641–647
  • [28] Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Aleman JO, Suzuki R, et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 2008,7,125–134 http://dx.doi.org/10.1016/j.cmet.2007.11.013[Crossref][WoS]
  • [29] Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Sing CF. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 2002,22,824–831 http://dx.doi.org/10.1161/01.ATV.0000014589.22121.6C[Crossref]
  • [30] Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000,8,605–619 http://dx.doi.org/10.1038/oby.2000.79[Crossref]
  • [31] Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs, evidence from a national cross sectional survey. BMJ 2000,321,1322–1325 http://dx.doi.org/10.1136/bmj.321.7272.1322[Crossref]
  • [32] Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002,39,203–208 http://dx.doi.org/10.1161/hy0202.103439[Crossref]
  • [33] de Souza LJ, Souto FJ, de Souza TF, Reis AF, Gicovate NC, Bastos DA, et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol 2003,81,249–264 http://dx.doi.org/10.1590/S0066-782X2003001100005[Crossref]
  • [34] Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, et al. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease, the PRIME Study. Int J Epidemiol 2005,34,268–275 http://dx.doi.org/10.1093/ije/dyh267[Crossref]
  • [35] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001,285,2486–2497
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_s11536-010-0075-9
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.